Compare Koninklijke Philips NV (PHG) vs S&P500 ETF (SPY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs S&P500 ETF — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while S&P500 ETF trades at $746.31. The key difference: Koninklijke Philips NV pays a 3.81% dividend while S&P500 ETF pays none, and S&P500 ETF is trading nearer its 52-week high, Koninklijke Philips NV nearer its low. Which is the better fit depends on your goals.
| PHG | SPY | |
|---|---|---|
Market Cap | $25.89B | — |
Sector | Health | — |
52-Week High | $32.91 | $759.55 |
52-Week Low | $25.02 | $621.75 |
Enterprise Value | $32.18B | — |
Dividend Yield | 3.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
SPY, the SPDR S&P 500 ETF, trades at $748.32, up 0.7% with a bearish technical bias as it faces resistance near $747-$754. The ETF reflects broad market dynamics, with recent news highlighting AI-driven industrial growth and concerns over S&P 500 valuations nearing historical highs. A dividend of $1.90 is scheduled for July 2026, providing income amid volatility.
Outlook remains cautious due to technical resistance and valuation concerns, but long-term exposure to large-cap US equities offers diversification. Risks include market overvaluation and economic headwinds, while institutional holdings support stability. Investors should weigh technical signals against fundamental market breadth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →
